$3.52
0.12.92%
After Hours: 5:26 PM EDT
Comments
Loading...
BioLine Rx Earnings Estimates, EPS & Revenue | NASDAQ:BLRX | Benzinga
BioLine Rx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 31
EPS Estimate
$0.000
Quarterly Revenue Estimate
$7.72M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$21.99M
Analyze the earnings history of BioLine Rx using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BLRX | BioLine Rx | -$0.01 | -$0.03 | — | — | $6.86M | $792.00K | — | — | 05/27/2025 | Get Alert |
| BLRX | BioLine Rx | -$0.15 | $0.00 | — | — | $4.80M | $7.72M | — | — | 03/31/2025 | Get Alert |
| BLRX | BioLine Rx | -$0.26 | -$0.10 | -$0.07 | 30.00% | $0.00 | $4.12M | $4.94M | 19.98% | 11/25/2024 | Get Alert |
| BLRX | BioLine Rx | -$0.30 | -$0.14 | $0.00 | 100.00% | $0.00 | $3.93M | $5.39M | 37.23% | 08/15/2024 | Get Alert |
| BLRX | BioLine Rx | -$0.10 | -$0.29 | -$0.01 | 96.55% | $0.00 | — | $6.86M | — | 05/28/2024 | Get Alert |
| BLRX | BioLine Rx | -$0.08 | -$0.22 | -$0.15 | — | $0.00 | — | $4.80M | — | 03/26/2024 | Get Alert |
| BLRX | BioLine Rx | -$0.02 | -$0.21 | -$0.26 | -23.81% | $0.00 | — | $0.00 | — | 11/20/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.02 | — | -$0.30 | — | $0.00 | — | $0.00 | — | 08/30/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.10 | — | -$0.10 | — | $0.00 | — | $0.00 | — | 05/24/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.18 | -$0.14 | -$0.08 | 42.86% | $0.00 | — | $0.00 | — | 03/22/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.01 | -$0.11 | -$0.15 | -36.36% | $0.00 | — | $0.00 | — | 11/15/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.15 | -$0.07 | -$0.15 | -114.29% | $0.00 | — | $0.00 | — | 08/16/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.02 | -$0.15 | -$0.10 | 33.33% | $0.00 | — | $0.00 | — | 05/11/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.60 | -$0.14 | -$0.18 | -28.57% | $0.00 | — | $0.00 | — | 03/16/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.30 | -$0.16 | -$0.15 | 6.25% | $0.00 | — | $0.00 | — | 11/18/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.45 | -$0.15 | -$0.15 | 0.00% | $0.00 | — | $0.00 | — | 08/18/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.60 | -$0.15 | -$0.30 | -100.00% | $0.00 | — | $0.00 | — | 05/26/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.90 | -$0.27 | -$0.60 | -122.22% | $0.00 | — | $0.00 | — | 02/23/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.45 | -$0.35 | -$0.30 | 14.29% | $0.00 | — | $0.00 | — | 11/23/2020 | Get Alert |
| BLRX | BioLine Rx | -$0.60 | -$0.73 | -$0.45 | 38.36% | $0.00 | — | $0.00 | — | 08/06/2020 | Get Alert |
| BLRX | BioLine Rx | -$0.75 | -$0.66 | -$0.60 | 9.09% | $0.00 | — | $0.00 | — | 05/20/2020 | Get Alert |
BioLine Rx (BLRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-25 | $-0.07 | $-0.10 | 30.0 % |
| Q2 | 2024-08-15 | $0 | $-0.14 | 100.0 % |
| Q1 | 2024-05-28 | $-0.01 | $-0.29 | 96.5 % |
| Q3 | 2023-11-20 | $-0.26 | $-0.21 | -23.8 % |
BioLine Rx (BLRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-25 | $4.94M | $4.12M | 20.0 % |
| Q2 | 2024-08-15 | $5.39M | $3.93M | 37.2 % |
FAQ
When is BioLine Rx (NASDAQ:BLRX) reporting earnings?
BioLine Rx (BLRX) is scheduled to report earnings on May 27, 2025. The last reported earnings were for reported on November 25, 2024 for Q3.
What were the latest earnings per share (EPS) for BioLine Rx (NASDAQ:BLRX)?
The Actual EPS was $-0.07, which beat the estimate of $-0.10.
What were BioLine Rx’s (NASDAQ:BLRX) revenues?
The Actual Revenue was $4.9M, which beat the estimate of $4.1M.
Browse earnings estimates, EPS, and revenue on all stocks.